Westborough, MA, United States of America

Anwar Murtaza

This inventor holds 8 USPTO granted patents and 9 published patent applications and 1 EPO patent. Top assignees: Abbvie Inc., Abbvie Biotechnology Ltd. Active years: 2014-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anwar Murtaza. Retrieved from https://idiyas.com/inventor/anwar-murtaza

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 9)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 10)

Average Co-Inventor Count = 12.5

ph-index = 6

Forward Citations = 86(Granted Patents)

Location History:

North Grafton, MA (US) (2014)
Westborough, MA (US) (2014 - 2017)

Company Filing History:

Abbvie Biotechnology Ltd

patents

Years Active: 2014-2017

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9663587 - IL-17 binding proteins (2017-05-30),

2. 9481736 - IL-17 binding proteins (2016-11-01),

3. 9481735 - IL-17 binding proteins (2016-11-01),

4. 9090689 - Use of TNFα inhibitor for treatment of psoriasis (2015-07-28),

5. 9085620 - Use of TNFα inhibitor for treatment of psoriatic arthritis (2015-07-21),

6. 8906373 - Use of TNF-alpha inhibitor for treatment of psoriasis (2014-12-09),

7. 8779101 - IL-17 binding proteins (2014-07-15),

8. 8624002 - Prostaglandin E2 binding proteins and uses thereof (2014-01-07),

Title: Anwar Murtaza: Innovator in IL-17 Binding Proteins

Introduction

Anwar Murtaza is a prominent inventor based in Westborough, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of proteins that target IL-17 and IL-17F. With a total of 8 patents to his name, Murtaza's work has the potential to impact the treatment and diagnosis of various IL-17 related diseases.

Latest Patents

Murtaza's latest patents focus on IL-17 binding proteins. These proteins are designed to bind IL-17 and/or IL-17F, and they are described along with their applications in compositions and methods for treating, preventing, and diagnosing IL-17 related diseases. Additionally, these patents detail methods for detecting IL-17 in cells, tissues, samples, and compositions.

Career Highlights

Throughout his career, Anwar Murtaza has worked with notable companies such as AbbVie Inc. and AbbVie Biotechnology Ltd. His experience in these organizations has allowed him to refine his expertise in biotechnology and contribute to innovative solutions in the medical field.

Collaborations

Some of Murtaza's coworkers include Edit Tarcsa and Chung-Ming Hsieh. Their collaborative efforts have likely played a role in advancing the research and development of IL-17 binding proteins.

Conclusion

Anwar Murtaza's contributions to the field of biotechnology, particularly through his patents on IL-17 binding proteins, showcase his innovative spirit and dedication to improving healthcare solutions. His work continues to pave the way for advancements in the treatment and diagnosis of IL-17 related diseases.

Profile summary based on public USPTO records.